BeOne Medicines (ONC) Shares Outstanding (2015 - 2026)

BeOne Medicines (ONC) has reported Shares Outstanding (Entity) for 12 consecutive years, with $1.5 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 9.81% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $1.5 billion (up 9.81% YoY), while the FY2025 annual figure was $1.5 billion, up 11.07% from the prior year.
• Shares Outstanding (Entity) was little changed at $1.5 billion in Q1 2026 per ONC's latest filing, from $1.5 billion in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $1.5 billion in Q2 2025 and bottomed at $1.3 billion in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2023.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) advanced 12.04% — and 2024, when it fell 0.23%.
• BeOne Medicines' Shares Outstanding (Entity) stood at $1.4 billion in 2022, then grew by 0.25% to $1.4 billion in 2023, then grew by 2.05% to $1.4 billion in 2024, then advanced by 11.07% to $1.5 billion in 2025, then changed by 0.0% to $1.5 billion in 2026.
• Business Quant data shows ONC's Shares Outstanding (Entity) at $1.5 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.5 billion in Q3 2025.